Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

NCT01548144 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

178

Enrollment

OTHER

Sponsor class

Stopped PI request

Conditions

Advanced Cancers

Interventions

DRUG: Crizotinib (Xalkori)
DRUG: Pazopanib
DRUG: Pemetrexed

Sponsor

M.D. Anderson Cancer Center